Every fact traced to its source, and checked against it. Explore the companies, facts, and conclusions behind the news.
Conclusions our AI is drawing from the traced facts — read them as interpretation, each grounded in the data and the entities it names.
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Enterprise software is being rebuilt around AI agents. Meta (Enterprise Platform, with MongoDB's CEO hired to lead it, plus in-house AI chips) and Alphabet (82% cloud growth) are pushing into the enterprise. AI-native startups such as Dextr AI, Latitude, Freehand, Groq and Black Forest Labs are raising capital, and investors like Norwest are mapping where finance and ERP software can be displaced. Incumbents are responding with acquisitions (Fortinet buying Virtue AI), raised guidance (UiPath), buybacks (74Software) and partner-program changes (HPE). Analysts and vendors such as EDB also stress that governance, data sovereignty and AI accuracy in finance are preconditions for regulated adoption.
Analyst coverage in mid-2026 splits along a clear line. AI-infrastructure and power names (Micron, Sandisk, ASML, Digital Realty, Bloom, NuScale) draw bullish ratings and raised guidance. Consumer and retail names (Wendy's, Gap, Nike, Levi's) face traffic weakness, abandoned deals and a K-shaped economy. Speculative frontier tech is under valuation pressure: D-Wave trades at 171x sales and SpaceX has fallen more than 40% from its highs. Biotech catalysts (the ivonescimab PDUFA date, Iovance's coverage resumption, Incyte's Vega deal) sit alongside these themes as a separate thread.
Q3 2026 brings a wave of CFO transitions (Rivian to GE Vernova, PJT Partners, Sanofi's finance scope expansion) alongside earnings-season guidance in which regional banks, led by Donald Hinson's commentary, report a net interest margin of 3.99% and say deposit costs have bottomed. Margin expansion is expected to slow, deposit competition is intensifying, and merger charges will fade by Q4. Near-term catalysts include Investor Days, capital markets events, a PDUFA date for ivonescimab and Durbin Amendment effects on Origin Bancorp from mid-2027.
Oncology is being reshaped by two converging forces. One is clinical validation of personalized mRNA cancer vaccines (Merck/Moderna's intismeran, with detailed ESMO data due 2026-10-24). The other is a shift toward AI-designed biologics at AstraZeneca, with agentic AI, automated labs and virtual trials aimed at compressing discovery timelines. Commercial results back this up: Q2 guidance was raised at oncology-heavy companies (Hematology and Oncology, Opzelura, Kiniksa) and Novocure posted record revenue. Regulatory catalysts are lined up, including the FDA PDUFA date for ivonescimab on 2026-11-14. Funding pressure remains at smaller biotechs, which are relying on cash runways and deals, such as ADC Therapeutics into 2028 and Treeline's transaction with Standard BioTools.
Capital is flowing into biotech and AI at scale. Four Series rounds of $275M to $550M closed on 2026-09-11, the OpenAI Foundation made $40M+ in health and data grants, and AI-designed drugs such as Rentosertib are reaching the clinic. Demand for GLP-1 drugs (Eli Lilly, Chinese drugmakers) and royalty-driven earnings (BioArctic's Leqembi) anchor the sector's fundamentals. Policy is moving toward industry self-regulation under a new AI czar while a jailbreak of Kimi models for bioweapon instructions and calls from Altman, Musk and Amodei to slow AI development raise biosecurity and governance risk.
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Samsung will likely announce a unified smart home AI platform or hub within 2-3 months that connects these disparate AI-enabled products
Sustained AI feature expansion across Samsung ecosystem in Q1-Q2 2026, with likely follow-up announcements for mobile devices and additional appliances
NVIDIA GPU acceleration is becoming the dominant infrastructure for AI chip design and EDA workflows, creating a self-reinforcing ecosystem where AI chips are designed using AI-accelerated tools
88% confidence · untestedData center infrastructure investments are shifting from traditional cloud providers to AI-specific facilities, with hyperscalers willing to commit $20B+ multi-year contracts for AI-optimized data center capacity, creating opportunities for specialized infrastructure developers
88% confidence · untestedLLM sycophancy is primarily caused by reinforcement learning from human feedback (RLHF) optimization for user approval rather than truthfulness, creating a systematic bias that degrades model reliability in extended conversations
85% confidence · untestedAI safety concerns are escalating as models gain access to classified and sensitive data, creating new security vulnerabilities and ethical challenges around training data governance
85% confidence · untestedHyperscaler AI infrastructure investments exceeding $200B combined will drive semiconductor demand and AI chip production capacity expansion in 2026
85% confidence · untestedFranklin Lexington Private Equities Secondaries Strategy Exceeds $3.5 Billion in Assets Under Management Globally Within First Year
“Franklin Lexington Private Equities Secondaries Strategy Exceeds $3.5 Billion in Assets Under Management Globally Within First Year Rapid Growth in Firm’s First Continuously Offered Private Equity Secondaries Strategy Highlights Strong Demand from Global Wealth Channel SAN MATEO, Calif., February 12, 2026--(BUSINESS WI…”
Sunset Pier 94 Studios Announces Inaugural Lease with Paramount Television Studios for Dexter®: Resurrection Ahead of Opening
“Sunset Pier 94 Studios Announces Inaugural Lease with Paramount Television Studios for Dexter®: Resurrection Ahead of Opening Paramount Television Studios Has Leased 70,000 Square Feet for Filming Season Two of the Hit Showtime® Original Series NEW YORK, January 15, 2026--(BUSINESS WIRE)--Today, Vornado Realty Trust (N…”
Tech stocks today: Nvidia stock rises as guidance signals AI boom alive and well
“Tech stocks today: Nvidia stock rises as guidance signals AI boom alive and well Nvidia (NVDA), the world's largest company by market capitalization, reported fourth quarter results after the closing bell on Wednesday in a highly anticipated release amid growing concerns about how big bets on AI will pay off…”
Stocks Settle Higher as SCOTUS Rejects President Trump’s Tariffs
“Stocks Settle Higher as SCOTUS Rejects President Trump’s Tariffs The S&P 500 Index ($SPX) (SPY) on Friday closed up +0.69%, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.47%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.87%…”
Wolfspeed Powers Toyota’s Electric Vehicle Platforms with Highly Reliable Silicon Carbide Components
“Wolfspeed Powers Toyota’s Electric Vehicle Platforms with Highly Reliable Silicon Carbide Components Underscores Wolfspeed’s leadership in silicon carbide power solutions, advancing Toyota’s global electrification strategy with enhanced efficiency and performance for battery electric vehicles…”
Energy Companies from Around the World Win Honors at S&P Global Energy's 27th Annual Platts Global Energy Awards
“Energy Companies from Around the World Win Honors at S&P Global Energy's 27th Annual Platts Global Energy Awards CNBC's Brian Sullivan Emceed as Winners from Australia, Brazil, China, Denmark, India, Singapore, Spain, UAE, UK, and US Were Announced NEW YORK, Dec…”
Two different margin values (16% vs 18%) are recorded for the same entity (Shopify Inc.) at the identical timestamp (2026-08-05 00:00:00). With no distinguishing context (same period designation, no qualifier for margin type), these represent conflicting data about the same fact.
Both facts measure EPS for Citigroup with identical observation dates (2025-12-31). FACT A explicitly specifies FY 2025 annual EPS at 6.99 USD/share, while FACT B reports 1.65 USD with an unspecified fiscal period (N/A). The values differ by a factor of ~4.2x, which is too large to explain by rounding, methodology, or data quality variance. While FACT B's 'N/A' fiscal period introduces ambiguity about whether it represents the same annual period, both observations are timestamped identically and purport to measure the same metric on the same date. If both represent FY 2025 annual EPS, this is a direct value conflict. If FACT B represents a different period (e.g., quarterly, TTM, or interim), the ambiguous labeling still constitutes a data quality issue that obscures the reconciliation.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
Both facts measure the same attribute (cash) for the same entity (Tesla Inc.) at the same point in time (2025-12-31). Although labeled with different fiscal period categories (FY 2025 vs Q4 2025), both periods end on the same date, making them equivalent time snapshots. The values differ drastically: $16.513 billion vs $44.06 USD. Since Q4 2025 is the final quarter of FY 2025, both should report identical cash balances at period-end. A 375 million-fold magnitude difference indicates a real contradiction, likely caused by a data quality issue (unit error, miscategorization, or source error in FACT B).
Both facts report EPS (earnings per share) for Tesla Inc. for the identical fiscal period (Q1 2026) and observation date (2026-03-31), but state conflicting values: 0.13 USD/share vs. 0.41 USD. Same entity, same metric, same time period, different reported values.
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Every fact is traceable to the document it came from — see how we source every claim.
A survey says 100% of organizations plan to use AI agents within two years, yet only about 45% of company data is AI-accessible. We checked the claims against sources, and the survey's publisher scored poorly on reliability, so we flag that. Nvidia's SEC-verified costs show the build-out is real.
Every company surveyed by MIT Technology Review plans to use AI agents within two years, yet firms with weak data give those agents access to 30% or less of it. Only some of this is firmly established: that survey's source scores 0% on our reliability check, and the Nvidia figures are SEC-verified.
Adobe's weak guidance, Alphabet's negative free cash flow, and a wave of safety-driven departures from Anthropic, Google and OpenAI show investors and insiders both demanding proof, not promises — even as California moves first to regulate AI's reach into children's lives.
A single summit produced roughly $950 billion in AI infrastructure deals and locked Nvidia into South Korea's memory supply chain, while one research firm says Wall Street is still underpricing the memory chip boom behind it. Here's what's verified, what's just one analyst's call, and what's still speculative.
C3.ai's CEO sold $4.8 million in stock the same week the industry's biggest AI-agent-trust survey turned out unreliable on 11 checked claims, even as Manulife, Box and a wave of banking and healthcare startups commit real budgets. Via News separates the verified from the unverified.
Google now lets users strip visible watermarks from Gemini-made images, video and music — a move that cuts against the story of an industry rushing toward stronger AI-content labeling, and lands the same week OpenAI lost another senior executive.
Nvidia and South Korea's chipmakers signed roughly $950 billion in new AI agreements in July, including a deal to help secure Nvidia's HBM memory supply from SK Hynix, even as chip stocks logged a sharp correction and the Nasdaq 100 hit a 2.75-month low. Via News traces the deals, earnings and balance-sheet data behind the divergence.
A late-July selloff cut deep into AI-chip stocks — Micron fell nearly 40% from its peak — even as Nvidia expanded its SK hynix memory deal, GlobalFoundries signed a $300M federal photonics award, and Skyworks-Qorvo named a combined leadership team. The data show a maturing boom repricing risk, not a broken one.
Nearly all enterprises surveyed say they'll deploy AI agents within two years, but agents can typically reach under half of company data — and as little as 30% at 'data laggard' firms. Platform giants are selling governance; a new wave of startups is skipping the data problem by targeting narrow, auditable back-office tasks instead.
Brad Lightcap, OpenAI's special projects lead and the company's former chief operating officer, has announced his departure from the company.
Insurer Manulife, software firm Box and data platform Snowflake are each rolling out enterprise AI agent tools this year, spanning insurance, content management and data operations worldwide. A fintech startup, Casap, is building agents for dispute resolution, while enterprise leaders across regions report unclear governance for the technology.
Micron and SanDisk are among 2026's top-performing chip stocks on AI memory demand, but both have fallen sharply from June record highs. Figures dated and sourced.
Jeff Dean and Sanjay Ghemawat quit Google within the same week to launch startup Discovery Loop, while Demis Hassabis stepped back from running DeepMind. Alphabet responded by investing in the new venture rather than treating the exits as a pure loss, a hedging strategy now spreading across global AI markets.
Oriol Vinyals, co-leader of Google's Gemini models, has left to co-found Discovery Loop, a new frontier AI venture. The move puts a veteran of one of the world's best-funded AI labs into a startup that must build compute, capital and talent from scratch amid intense global competition.
Bloom Energy signed a $1.7 billion fuel-cell agreement with Nebius AI, one of the largest on-site power deals for AI data centers to date. The company also struck a deal with utility giant AEP and expanded distribution in South Korea, showing on-site generation is now a global bottleneck for AI buildout.
Bloom Energy signed three fuel-cell partnerships in quick succession, led by a $1.7 billion deal with Nebius AI, plus deals with US utility AEP and South Korea's SK Ecoplant and SK Eternix. Analysts say the geographic spread signals a global scramble for AI data center power beyond traditional grid capacity.
A cluster of AI-native drug discovery platforms launched worldwide in early-to-mid 2026, all running on NVIDIA GPU infrastructure. Novo Nordisk's decision to outsource cell therapy research to an AI-native partner signals a broader industry shift from in-house labs to external, GPU-powered specialists.
BlackRock priced a $12.5 billion bond tied to the Meta-BlackRock Texas Data Center Complex at a steep 7.53% yield after weak demand from investors worldwide. Credit-default swaps on major AI-linked firms jumped in tandem, signaling that credit markets globally are pricing AI infrastructure risk far more cautiously than equity markets.
KLA raised its 2026 wafer fabrication equipment forecast to the low-$150 billion range, citing AI chip demand. The California-based supplier also lifted quarterly revenue guidance to $4 billion and its advanced packaging target to $1.1 billion, alongside a 10-for-1 stock split.
Amkor Technology posted record second-quarter revenue as AI demand lifted chip packaging volumes, though weaker Q3 guidance points to uneven growth. Nvidia, the U.S. government, and chipmakers on three continents are all moving capital and consolidating to keep pace with AI infrastructure demand.
KLA Corporation lifted its advanced-packaging process control revenue forecast to about $1.1 billion, up 70% year-over-year, citing sustained AI infrastructure demand worldwide. The growth concentrates in one niche tied to chip packaging hubs in Taiwan, South Korea and the US, raising structural risk if global AI capex slows.
KLA CFO Bren Higgins says US export restrictions are ceding Chinese semiconductor-fab market share to non-US rivals unbound by the same rules. The disclosure places KLA alongside Applied Materials and Lam Research in flagging China controls as a recurring earnings drag, part of a wider realignment of the global chip-equipment supply chain.
SunPower's gross profit fell 41% to $27.6M last quarter, far outpacing a 23% revenue decline to $56M. New CFO Tom Kowalczuk inherits a margin gap that mirrors pressure across the global solar sector, from China to Europe.
Crypto exchange MEXC is expanding into traditional assets like stocks and bonds, a move regulators worldwide could flag as unlicensed securities activity. A risk assessment dated August 1, 2026 rates the threat as major severity with medium likelihood, and CEO Vugar's public role puts him at direct personal exposure.
Alphabet raised its 2026 capital expenditure forecast to $205 billion to fund AI infrastructure, up from prior guidance. Shares fell as investors weighed near-term cash flow costs against long-term AI revenue. The move intensifies a global race among hyperscalers for chips, GPUs and data center capacity.
Microsoft and Snowflake rolled out new governed AI agent platforms this week, extending deployments from Manulife's global insurance operations to Fanatics, Thomson Reuters and WHOOP. Surveys show enterprise leaders worldwide still lack a clear roadmap for who owns and secures these systems.
Every fact here is structured and source-traced — so AI systems inherit ground truth, not re-narrated claims. The same facts a person reads, a model can query.